Breaking News Instant updates and real-time market news.

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

17:45
12/05/19
12/05
17:45
12/05/19
17:45

Morgan Stanley upgrades Epizyme to Overweight ahead of lymphoma data

Morgan Stanley analyst David Lebowitz upgraded Epizyme to Overweight from Equal Weight with a price target of $22, up from $12. The stock in after-hours trading is up 3%, or 40c, to $15.70. The analyst expects data this weekend at the American Society of Hematology meeting to bolster confidence in tazemetostat for follicular lymphoma. The data, which will include more mature results and median progression-free survival in the mutant patients, should be "incrementally positive," Lebowitz tells investors in a research note. The analyst raised his 2021 adjusted tazemetostat sales estimate to $23M from $18M and 2026 estimate to $733M from $377M.

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

EPZM Epizyme
$15.32

-0.48 (-3.04%)

12/05/19
MSCO
12/05/19
UPGRADE
Target $22
MSCO
Overweight
Epizyme upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst David Lebowitz upgraded Epizyme to Overweight from Equal Weight with a $22 price target.
06/13/19
HCWC
06/13/19
NO CHANGE
Target $25
HCWC
Buy
Epizyme selloff yesterday an overreaction, says H.C. Wainwright
Yesterday, Epizyme's abstract to be presented at the International Conference on Malignant Lymphoma indicated a slip of the median duration of response in EZH2 wild type patients, H.C. Wainwright analyst Andrew Fein tells investors in a research note. He believes the stock overreacted due to concern "about a possible regulatory hiccup and a potentially narrower label." The analyst, however, continues to believe tazemetostat's data package should support a broad label in follicular lymphoma. He reiterates a Buy rating on Epizyme with a $25 price target.
05/30/19
SBSH
05/30/19
INITIATION
Target $25
SBSH
Buy
Epizyme assumed with a Buy at Citi
Citi analyst Mohit Bansal assumed coverage Epizyme with a Buy rating and $25 price target. Under a prior analyst, Citi had a Buy rating on the shares with a $28 price target.
02/27/19
OPCO
02/27/19
NO CHANGE
Target $18
OPCO
Outperform
Epizyme price target lowered to $18 from $27 at Oppenheimer
Oppenheimer analyst Leland Gershell lowered Epizyme's price target to $18 from $27 after assuming coverage of the name with an Outperform rating. Impressive efficacy in r/r follicular lymphoma demonstrated by lead candidate tazemetostat should enable this drug to become the 3rd line treatment of choice in the about 20% w/EZH2-activating mutations as well as drive its use within the wild-typep opulation, he contends, adding that an NDA submission for all-comers is expected in Q4 of 2019.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,895.31

3.03 (0.16%)

12:58
01/22/20
01/22
12:58
01/22/20
12:58
Hot Stocks
Mark Cuban says Amazon.com remains largest holding »

Mark Cuban said on CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

12:55
01/22/20
01/22
12:55
01/22/20
12:55
Conference/Events
Stephens food analysts to hold an analyst/industry conference call »

Analysts provide an…

12:55
01/22/20
01/22
12:55
01/22/20
12:55
Conference/Events
Senate Impeachment Trial of President Trump--Day 3 »

The Senate impeachment…

NTDOY

Nintendo

$0.00

(0.00%)

12:51
01/22/20
01/22
12:51
01/22/20
12:51
Periodicals
Nintendo wins court case in Germany over pre-orders, Nintendo Everything says »

Nintendo has prevailed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$318.56

2.17 (0.69%)

, GOOG

Alphabet

$1,493.73

8.81 (0.59%)

12:48
01/22/20
01/22
12:48
01/22/20
12:48
Periodicals
Google researchers find multiple security flaws in Apple's Safari, FT reports »

Researchers at Google…

AAPL

Apple

$318.56

2.17 (0.69%)

GOOG

Alphabet

$1,493.73

8.81 (0.59%)

GOOGL

Alphabet Class A

$1,491.43

8.73 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 28

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

ARWR

Arrowhead

$48.17

0.54 (1.13%)

12:45
01/22/20
01/22
12:45
01/22/20
12:45
Options
Arrowhead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

MSI

Motorola Solutions

$177.26

0.29 (0.16%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
Motorola presales for foldable 'revived' Razr begin January 26, Engadget says »

After delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
French minister says France, U.S. agree on digital tax framework, AP reports »

France intends to delay…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:37
01/22/20
01/22
12:37
01/22/20
12:37
Conference/Events
Wolfe Research utilities/midstream analysts to hold luncheon meeting »

Utilities & Power…

CMCSA

Comcast

$47.44

0.13 (0.27%)

12:35
01/22/20
01/22
12:35
01/22/20
12:35
Periodicals
Olympic qualifiers moved or canceled due to coronavirus, CNN reports »

The International Olympic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DIS

Disney

$143.99

0.46 (0.32%)

12:33
01/22/20
01/22
12:33
01/22/20
12:33
Hot Stocks
Scopely acquires FoxNext Games, Cold Iron Studios from Disney »

Scopely and The Walt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

, PUGOY

Peugeot

$0.00

(0.00%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Periodicals
Fiat Chrysler CEO says PSA deal talks 'progressing really well,' Reuters says »

Fiat Chrysler (FCAU) CEO…

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

PUGOY

Peugeot

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.66

0.345 (6.49%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Conference/Events
The Executives' Club of Chicago to hold a luncheon meeting »

The Executives' Club…

SRPT

Sarepta

$121.03

-1.65 (-1.34%)

12:24
01/22/20
01/22
12:24
01/22/20
12:24
Periodicals
New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says »

New documents released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$1.96

0.04 (2.08%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Hot Stocks
Proteostasis to present data from organoid study in CF treatment »

Proteostasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNA

Moderna

$21.97

1 (4.77%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Recommendations
Moderna analyst commentary  »

Moderna mRNA technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/22/20
01/22
12:15
01/22/20
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude hit…

TWLO

Twilio

$119.62

0.47 (0.39%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
Periodicals
Breaking Periodicals news story on Twilio »

Hedgeye adds Twilio to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 24

    Feb

NFLX

Netflix

$332.00

-6.24 (-1.84%)

, IBM

IBM

$143.22

4.07 (2.92%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rebounding…

NFLX

Netflix

$332.00

-6.24 (-1.84%)

IBM

IBM

$143.22

4.07 (2.92%)

AAPL

Apple

$318.43

2.04 (0.64%)

ETN

Eaton

$97.23

2.72 (2.88%)

ABT

Abbott

$92.33

2.57 (2.86%)

NAVI

Navient

$15.02

1.16 (8.37%)

ARNC

Arconic

$28.60

-0.795 (-2.71%)

FCEL

FuelCell

$2.14

-0.735 (-25.61%)

NTRS

Northern Trust

$102.32

-6.35 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 04

    Feb

NTDOY

Nintendo

$0.00

(0.00%)

12:09
01/22/20
01/22
12:09
01/22/20
12:09
Periodicals
Judge says iLife's patent suit against Nintendo not valid, Verge says »

Federal Judge Barbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WILC

G. Willi-Food

$12.22

-0.21 (-1.69%)

12:06
01/22/20
01/22
12:06
01/22/20
12:06
Hot Stocks
G. Willi-Food CEO Michael Luboschitz to resign for personal reasons »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.41

0.77 (2.51%)

12:05
01/22/20
01/22
12:05
01/22/20
12:05
Options
Elanco Animal Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.